Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

148.40 

0.70 0.5%

as of Jul 22 '19

52 Week Range:

79.65 148.80


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. It offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as systems for storage and transportation of intermediate and finished biological products. The company also provides cell cultivation, fermentation, filtration, purification, and fluid management services, which supports its customers to develop and produce drugs. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 3.64
3.86
3.58
4.03
4.22
4.39
5.29
6.31
7.28
8.64
9.95
growth rate 6.0% -7.3% 12.6% 4.7% 4.0% 20.5% 19.3% 15.4% 18.7% 15.2%
Earnings BIT 21.21
41.67
55.99
64.67
83.46
104.66
121.47
196.99
241.12
250.79
286.88
growth rate 96.5% 34.4% 15.5% 29.1% 25.4% 16.1% 62.2% 22.4% 4.0% 14.4%
Avg.PE 16.95
16.42
15.80
17.48
19.88
28.25
42.01
49.29
41.26
41.77
51.10
growth rate -3.1% -3.8% 10.6% 13.7% 42.1% 48.7% 17.3% -16.3% 1.2% 22.3%
ROA 2.02
4.41
5.82
6.25
7.49
7.96
8.15
11.96
13.59
12.39
13.99
growth rate 118.3% 32.0% 7.4% 19.8% 6.3% 2.4% 46.8% 13.6% -8.8% 12.9%
ROE 3.57
7.63
10.16
11.34
13.74
14.56
14.34
20.10
21.96
19.77
21.80
growth rate 113.7% 33.2% 11.6% 21.2% 6.0% -1.5% 40.2% 9.3% -10.0% 10.3%
ROIC 3.94
6.35
7.97
9.13
10.74
11.43
11.93
17.16
19.36
17.35
19.17
growth rate 61.2% 25.5% 14.6% 17.6% 6.4% 4.4% 43.8% 12.8% -10.4% 10.5%
Cur. Ratio 1.66
1.55
1.22
1.31
0.98
1.67
1.20
1.29
1.52
1.40
1.45
growth rate -6.6% -21.3% 7.4% -25.2% 70.4% -28.1% 7.5% 17.8% -7.9% 3.6%
Quick Ratio 0.89
1.05
0.77
0.83
0.52
0.97
0.65
0.67
0.80
0.73
0.69
growth rate 18.0% -26.7% 7.8% -37.4% 86.5% -33.0% 3.1% 19.4% -8.8% -5.5%
Leverage 1.76
1.70
1.80
1.83
1.84
1.82
1.70
1.66
1.58
1.61
1.52
growth rate -3.4% 5.9% 1.7% 0.6% -1.1% -6.6% -2.4% -4.8% 1.9% -5.6%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 74.07
70.46
86.00
96.00
99.00
115.27
133.68
154.57
206.64
237.62
235.77
growth rate -4.9% 22.1% 11.6% 3.1% 16.4% 16.0% 15.6% 33.7% 15.0% -0.8%
Acct.Payable 35.00
44.00
40.00
51.62
49.18
61.36
67.99
77.21
103.57
growth rate 25.7% -9.1% 29.1% -4.7% 24.8% 10.8% 13.6% 34.1%
Cur.Assets 163.21
185.57
176.00
220.00
226.00
260.91
276.17
350.83
431.73
490.85
552.53
growth rate 13.7% -5.2% 25.0% 2.7% 15.5% 5.9% 27.0% 23.1% 13.7% 12.6%
Total Assets 652.30
667.90
656.00
721.00
794.00
873.42
907.34
1,066.14
1,195.85
1,403.91
1,571.46
growth rate 2.4% -1.8% 9.9% 10.1% 10.0% 3.9% 17.5% 12.2% 17.4% 11.9%
Cash 13.20
54.80
30.00
47.00
28.00
35.61
18.54
31.83
34.76
32.55
23.98
growth rate 315.2% -45.3% 56.7% -40.4% 27.2% -47.9% 71.7% 9.2% -6.3% -26.4%
Inventory 60.92
46.72
51.00
66.00
85.00
94.94
109.98
146.97
171.06
185.60
252.00
growth rate -23.3% 9.2% 29.4% 28.8% 11.7% 15.8% 33.6% 16.4% 8.5% 35.8%
Cur.Liabilities 98.11
119.69
145.00
168.00
230.00
157.89
229.58
272.69
284.36
350.44
381.98
growth rate 22.0% 21.2% 15.9% 36.9% -31.4% 45.4% 18.8% 4.3% 23.2% 9.0%
Liabilities 280.70
274.70
291.00
325.00
359.00
391.58
368.25
418.92
432.29
524.45
526.59
growth rate -2.1% 5.9% 11.7% 10.5% 9.1% -6.0% 13.8% 3.2% 21.3% 0.4%
LT Debt 130.80
104.10
92.00
84.00
26.00
122.48
15.88
12.60
9.38
46.25
43.13
growth rate -20.4% -11.6% -8.7% -69.1% 371.1% -87.0% -20.6% -25.6% 393.3% -6.8%
Equity 371.60
393.20
365.10
395.60
435.00
478.34
532.45
641.44
758.01
872.03
1,036.40
growth rate 5.8% -7.2% 8.4% 10.0% 10.0% 11.3% 20.5% 18.2% 15.0% 18.9%
Common Shares 102.00
102.00
97.00
92.00
92.00
92.00
92.00
92.00
92.00
92.00
92.00
growth rate 0.0% -4.9% -5.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 12.70
9.10
12.00
33.00
39.00
29.28
47.07
52.99
79.71
126.83
176.54
growth rate -28.4% 31.9% 175.0% 18.2% -24.9% 60.8% 12.6% 50.4% 59.1% 39.2%
Cash Dividends 5.10
5.10
10.20
13.80
15.30
16.88
18.41
19.97
30.73
38.71
42.40
growth rate 0.0% 100.0% 35.3% 10.9% 10.3% 9.1% 8.5% 53.9% 26.0% 9.5%
Cash From OA 47.20
91.90
73.00
61.00
49.00
90.11
111.31
142.79
156.66
174.69
227.29
growth rate 94.7% -20.6% -16.4% -19.7% 83.9% 23.5% 28.3% 9.7% 11.5% 30.1%
FCF per Share 0.26
0.74
0.58
0.44
0.11
0.34
0.81
0.88
0.71
0.79
0.60
growth rate 184.6% -21.6% -24.1% -75.0% 209.1% 138.2% 8.6% -19.3% 11.3% -24.1%
Sale Purchase of Stock 0.01
0.14
0.18
growth rate 1,340.0% 21.5%
FCF 27.00
76.00
56.00
22.00
10.00
61.00
64.00
90.00
77.00
48.00
51.00
growth rate 181.5% -26.3% -60.7% -54.6% 510.0% 4.9% 40.6% -14.4% -37.7% 6.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 368.00
401.20
433.00
477.00
544.00
588.38
683.52
884.33
1,051.61
1,081.03
1,212.15
growth rate 9.0% 7.9% 10.2% 14.1% 8.2% 16.2% 29.4% 18.9% 2.8% 12.1%
Op.Income 33.70
48.60
39.00
43.00
58.00
104.66
121.47
196.99
241.12
250.79
286.88
growth rate 44.2% -19.8% 10.3% 34.9% 80.4% 16.1% 62.2% 22.4% 4.0% 14.4%
IBT 21.20
41.70
56.00
64.70
81.90
94.44
105.05
169.68
212.99
220.61
284.55
growth rate 96.7% 34.3% 15.5% 26.6% 15.3% 11.2% 61.5% 25.5% 3.6% 29.0%
Net Income 13.10
29.10
39.00
43.00
58.00
66.28
72.44
118.00
153.68
161.09
208.05
growth rate 122.1% 34.0% 10.3% 34.9% 14.3% 9.3% 62.9% 30.2% 4.8% 29.2%
EPS 0.13
0.28
0.40
0.47
0.62
0.72
0.79
1.28
1.67
1.75
2.26
growth rate 115.4% 42.9% 17.5% 31.9% 16.1% 9.7% 62.0% 30.5% 4.8% 29.1%
Gross Profit 175.80
190.30
216.00
238.00
273.00
293.13
337.21
451.79
526.82
554.83
629.56
growth rate 8.3% 13.5% 10.2% 14.7% 7.4% 15.0% 34.0% 16.6% 5.3% 13.5%
R&D 24.50
24.50
27.80
28.60
31.80
36.00
34.12
41.53
47.54
53.21
60.62
growth rate 0.0% 13.5% 2.9% 11.2% 13.2% -5.2% 21.7% 14.5% 11.9% 13.9%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 57.60
72.10
72.60
84.68
80.00
growth rate 25.2% 0.7% 16.6% -5.5%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 241.20
247.80
255.40
235.77
248.70
growth rate 2.7% 3.1% -7.7% 5.5%
Acct.Payable 126.50
154.00
155.60
103.57
167.10
growth rate 21.7% 1.0% -33.4% 61.3%
Cur.Assets 535.80
531.30
595.50
552.53
587.20
growth rate -0.8% 12.1% -7.2% 6.3%
Total Assets 1,457.20
1,505.00
1,585.10
1,571.46
1,660.40
growth rate 3.3% 5.3% -0.9% 5.7%
Cash 42.70
25.80
56.70
23.98
25.80
growth rate -39.6% 119.8% -57.7% 7.6%
Inventory 203.00
215.70
240.00
252.00
269.90
growth rate 6.3% 11.3% 5.0% 7.1%
Cur.Liabilities 366.40
411.40
440.60
381.98
436.90
growth rate 12.3% 7.1% -13.3% 14.4%
Liabilities 541.80
580.10
609.40
526.59
604.70
growth rate 7.1% 5.1% -13.6% 14.8%
LT Debt 45.50
44.40
43.60
43.13
42.80
growth rate -2.4% -1.8% -1.1% -0.8%
Equity 907.70
917.30
967.60
1,036.40
1,046.80
growth rate 1.1% 5.5% 7.1% 1.0%
Common Shares 18.40
18.40
18.40
18.44
18.40
growth rate 0.0% 0.0% 0.2% -0.2%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 27.40
64.20
35.00
49.94
32.30
growth rate 134.3% -45.5% 42.7% -35.3%
Cash Dividends 42.40
42.40
0.00
0.00
growth rate 0.0% -100.0% 0.0%
Cash From OA 38.30
67.80
54.50
66.69
80.80
growth rate 77.0% -19.6% 22.4% 21.2%
Sale Purchase of Stock
growth rate
FCF 10.90
3.60
19.50
16.75
48.50
growth rate -67.0% 441.7% -14.1% 189.6%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 281.10
304.60
310.40
316.05
342.90
growth rate 8.4% 1.9% 1.8% 8.5%
Op.Income 57.60
72.10
72.60
84.68
80.00
growth rate 25.2% 0.7% 16.6% -5.5%
IBT 55.90
68.50
67.30
92.75
76.40
growth rate 22.5% -1.8% 37.8% -17.6%
Net Income 40.90
50.10
49.40
67.65
56.10
growth rate 22.5% -1.4% 37.0% -17.1%
EPS
growth rate
Gross Profit 147.30
159.10
164.90
158.36
177.30
growth rate 8.0% 3.7% -4.0% 12.0%
R&D 17.10
15.00
16.10
12.42
17.70
growth rate -12.3% 7.3% -22.9% 42.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (80.79)

YOY Growth Grade:

C (65.72)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 60.81 61.10 53.72
EPS / Growth 26.3% 2.43 11.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 15.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.0% 17.6% 17.6%
Future PE 22.00 49.89 49.89
Future EPS 6.90 12.26 12.26
Value Price
MOS %
37.51
-74.7%
151.15
1.9%
151.15
1.9%
MOS Price 18.75 75.58 75.58
IRT 18.71 14.29 14.29

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.